Skip to main content
Equibles
SABS logo

SABS · SAB Biotherapeutics, Inc. · Analyst Estimates

Track SABS — free

Use SABS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SABS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.41 -0.01 (-0.29%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$310.26M
Shares
90.99M

Analyst Estimates

Compare analyst forecasts for SAB Biotherapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 55 filings 55 filers Visit website Investor relations